HIV TREATMENT
2020
Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.
Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.
Paediatric HIV & TB : Rome Action Plan
High-Level Dialogue on
Paediatric HIV and TB in Children Living with HIV (ROME 5)
Virtual, 5-6 November 2020
High-Leve Dialogue (ROME 5) - Concept
November 5, 2020
High-Level Dialogue on Paediatric HIV and TB in Children Living with HIV concept note.
High-Leve Dialogue (ROME 5) - Agenda
November 5, 2020
High-Level Dialogue on Paediatric HIV and TB in Children Living with HIV agenda.
Rome Action Plan Progress Report 2018-2020
November 5, 2020 - Opening Session
Presentation of the 2018 ROME ACTION PLAN PROGRESS REPORT
December 2018 – November 2020
Rome Action Plan Progress Presentation
November 5, 2020 - Opening Session - Chip Lyons, EGPAF
Presentation of the Rome Action Plan Progress Report 2018-2020
HIV among children Status update
November 5, 2020 - Opening Session - Shannon Hader, UNAIDS
Status update on HIV among children
Challenges & Opportunities
November 5, 2020 - Session 1 TB - Blessina Kumar, GCTA
Challenges and Opportunities to address during High- Level Dialogue
TB in Children and Adolescents
November 5, 2020 - Session 1 TB- Dr. Tereza Kasaeva, WHO GTB
Presentation on TB in Children and Adolescents
Highlights Session 1TB
November 5, 2020 - Session 1 TB - Fr. Richard Bauer, EDARP
Highlights of Session 1
Scene Setter - R&D HIV Diagnostics for Children
November 5, 2020 - Session 2 R&D Diagnostics - Dr. Lara Vojnov, WHO
Setting the scene: Research & Development of HIV Diagnostics for Children
Scene Setter - TB Diangostics for Children
November 5, 2020 - Session 2 R&D Diagnostics - Dr. Nazir Ismail, WHO/GTB
Setting the scene: TB diagnostics for Children
Highlights Session 2 - R&D Diagnostics
November 5, 2020 - Session 2 R&D Diagnostics - Cheri Vincent, USAID
Highlights of Session 2
Scene Setter - R&D Medicines for Children
November 5, 2020 - Session 3 R&D Medicines - Lindsay McKenna, TAG
Setting the scene: Research & Development of TB Medicines for Children
Scene Setter - R&D Medicines for Children
November 5, 2020 - Session 3 R&D Medicines - Dr. Martina Penazzato, WHO
Setting the scene: Research & Development of Medicines for Children
Summary Day 1 & Overview Day 2
November 5, 2020 - Session 3 R&D Medicines - Dr. Meg Doherty, WHO
Summary of Day 1 and Overview of Day 2
Scene Setter - Identifying & Diagnosing Children
November 6, 2020 - Session 5 Identifying and Diagnosing Children - Jeff Lemaire, EGPAF
Setting the Scene on identifying and diagnosing children exposed to HIV and to TB
Scene Setter - Introduction & Scale-up Medicines for Children
November 6, 2020 - Session 6 Introduction and Scale-up of Medicines - Dr Brenda Waning, STBP
Setting the Scene on Introduction and Scale Up of TB Medicines for Children
Review of commitments on diagnostics and medicines
November 6, 2020 - Session 7 Commitments & Accountability - Dr Meg Doherty, WHO
Review of commitments on diagnostics and medicines
Accountability
November 6, 2020 - Session 7 Commitments & Accountability - Chip Lyons, EGPAF
Accountability Framework